Identification of N-hydroxamic acid and N-hydroxy-imide compounds that inhibit the influenza virus polymerase

Antiviral Chemistry and Chemotherapy

Volumn 7, Issue 6, 1996, Pages 353-360

  Cianci, C ^a   Chung, T D Y ^a,b   Meanwell, N ^a   Putz, H ^a   Hagen, M ^a,c   Colonno, R J ^a   Krystal, M ^a  

^a BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

^b PHARMACOPEIA INC   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

endonuclease; influenza; inhibitor; N hydroxamic acid; N hydroxy imide; polymerase

Indexed keywords

ANTIVIRUS AGENT; DRUG CARRIER; ENDONUCLEASE; MESSENGER RNA; RNA DIRECTED RNA POLYMERASE; VIRUS ENZYME;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SCREENING; ENZYME INHIBITION; GENETIC TRANSCRIPTION; INFLUENZA VIRUS; NONHUMAN; PRIORITY JOURNAL; RNA SYNTHESIS; STRUCTURE ACTIVITY RELATION;

EID: 0029800910     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632029600700609     Document Type: Article

References (42)

1. Banerjee, A.K. (1987) The transcription complex of vesicular stomatitis virus. Cell 48: 363-364.
2. Banerjee, A.K., Moyer, S.A., and Rhodes, D.P. (1974) Studies on the in vitro adenylation of RNA by vesicular stomatitis virus. Virology 61: 547-558.
3. Barbosa, E., and Moss, B. (1978) mRNA(nucleoside-2′)-methyltransferase from vaccinia virus. Purification and physical properties. J Biol Chem 253: 7692-7697.
4. Barrett, T., and Inglis, S.C. (1985) Growth, purification and titration of influenza viruses. In Virology: A Practical Approach. Mahy, B.W.J. (ed.). Oxford: IRL Press, pp. 119-150.
5. Betts, R.F. (1991) Resistance to rimantadine and amantadine. Current Opinion in Infections Diseases 4: 804-808.
6. Betts, R.F. (1992) Potential agents in the treatment of influenza. Current Opinion in Infections Diseases 5: 811-815.
7. Bishop, D.H.L., Obijeski, J.F., and Simpson, R.W. (1971) Transcription of the influenza ribonucleic acid genome by a virion polymerase. I. Optimal condition for in vitro activity of the ribonucleic acid-dependent ribonucleic acid polymerase. J Virol 8: 66-71.
8. Blok, V., Cianci, C., Tibbles, K.W., Inglis, S.C., Krystal, M., and Digard, P. (1996) Inhibition of the Influenza virus RNA-dependent RNA polymerase by antisera directed against the PB2 subunit. J Gen Virol 77: 1025-1033.
9. Braam, J., Ulmanen, I., and Krug, R.M. (1983) Molecular model of a eukaryotic transcription complex: functions and movements of influenza P proteins during capped RNA-primed transcription. Cell 34: 609-618.
10. Chung, T.D.Y., Cianci, C., Hagen, M., Terry, B.T., Matthews, J.T., Krystal, M., and Colonno, R.J. (1994) Biochemical studies on capped RNA primers identify a class of oligonucleotide inhibitors of the influenza virus RNA polymerase. Proc Natl Acad Sci USA 91: 2372-2376.
11. Cianci, C., Tiley, L., and Krystal, M. (1995) Differential activation of the influenza virus polymerase via template RNA binding. J Virol 69: 3995-3999.
12. Couch, R.B. (1993) Advances in influenza virus vaccine research. Ann NY Acad of Sci 685: 803-812.
13. Drummond, J., Johnson, G., Nickell, D.G., Ortwine, D.F., Bruns, R.F., and Welbaum, B. (1989) Evaluation and synthesis of amino-hydroxy isooxazoles and pyrazoles as potential glycine agonists. J Med Chem 32: 2116-2128.
14. Gorman, O.T., Donis, R.O., Kawaoka, Y., and Webster, R.G. (1990) Evolution of influenza A virus PB2 genes: implications for evolution of the ribonucleoprotein complex and origin of human influenza A virus. J Virol 64: 4893-4902.
15. Hagen, M., Chung, T.D.Y., Butcher, J.A., and Krystal, M. (1994) Recombinant influenza virus polymerase: requirement of both 5′ and 3′ viral ends for endonuclease activity. J Virol 68: 1509-1515.
16. Hastings, J.C., Selnick, H., Wolanski, B., and Tomassini, J.E. (1996) Anti-influenza virus activities of 4-substituted 2,4-dioxobutanoic acid inhibitors. Antimicrob Agents Chemother 40: 1304-1307.
17. Hay, A.J. (1992) The action of adamantanamines against influenza A viruses: inhibition of the M2 ion channel protein. Seminars in Virology 3: 21-30.
18. Hayden, F.G., and Couch, R.B. (1992) Clinical and epidemiological importance of influenza A viruses resistant to amantadine and rimandatine. Medical Virol 2: 89-96.
19. Hayden, F.G., and Hay, A.J. (1992) Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine. Current Topics in Microbiol and Immunol 176: 119-130.
20. Hayden, F.G., Sperber, S.J., Belshe, R.B., Clover, R.D., Hay, A.J., and Pyke, S. (1991) Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine. Antimicrob Agents Chemother35: 1741-1747.
21. Hensens, O.D., Goetz, M.A., Liesch, J.M., Zink, D.L., Raghoobar, S.L., Helms, G.L., and Singh, S.B. (1995) Isolation and structure of flutimide, a novel endonuclease inhibitor of influenza virus. Tet Lett 36: 2005-2008.
22. Ishihama, A., and Nagata, K. (1988) Viral RNA polymerases. CRC Critical Reviews in Biochem 23: 27-76.
23. Kawakami, K., Mizumoto, K., Ishihama, A., Shinozaki-Yamguchi, K., and Kin-Ichiro, M. (1985) Activation of influenza virus-associated RNA polymerase by cap-1 structure (m7GpppNm). J Biochem 97: 655-661.
24. Koper-Zwarthoff, E.C., Brederode, F.T., Veeneman, G., Van Boom, J.H., and Bol, J.F. (1980) Sequences at the 5′ termini of the alfalfa mosaic virus RNAs and the intercistronic junction in RNA 3. Nucl Acids Res 8: 5635-5647.
25. Krug, R.M. (1981) Priming of influenza viral RNA transcription by capped heterologous RNAs. Current Topics Microbiol Immunol 93: 125-150.
26. Krug, R.M., Broni, B.A., LaFiandra, A.J., Morgan, M.A., and Shatkin, A.J. (1980) Priming and inhibitory activities of RNA's for the influenza viral transcriptase do not require base pairing with the virion template RNA. Proc Natl Acad Sci USA 77: 5874-5878.
27. Krug, R.M., Alonso-Caplen, F.V., Julkunen, I., and Katze, M.G. (1989) Expression and replication of the influenza virus genome. In The Influenza Viruses. Krug, R.M. (ed.). New York: Plenum Press, pp. 89-152.
28. Lamb, R.A., and Choppin, P.W. (1983) The gene structure and replication of influenza virus. Ann Rev Biochem 52: 467-506.
29. Martell, A.E., and Smith, R.M. (1982) In Critical Stability Constants. New York: Plenum Press. 6: 378-379.
30. 7GpppXm)-dependent influenza virion endonuclease cleaves capped RNA's to generate the primers that initiate viral RNA transcription. Cell 23: 847-858.
31. Raymond, K.N., Chung, T.D.Y., Pecararo, V.L., and Carrano, C.J. (1982) Iron removal from transferrin by siderophores and analogs, and determination of the number of bound tyrosines in metal transferrin complexes. In The Biochemistry and Physiology of Iron. Saltman, P., and Hegenauer, J. (eds). New York: Elsevier Press Biomedical, pp. 649-662.
32. Rochavansky, O.M. (1976) RNA synthesized by ribonucleoprotein polymerase complexes isolated from influenza virus. Virology 73: 327-338.
33. Romine, J.L., Martin, S.W., Meanwell, N.A., and Epperson, J.R. (1994) Synthesis of 3-hydroxypyridine-2,4-diones. Addition of anilines to benzyloxy isocyanate to give N-hydroxy ureas. Synthesis 8: 846-850.
34. Scholtissek, C. (1978) The genome of the influenza virus. Current Topics Microbiol Immunol 80: 139-169.
35. Shi, L., Summers, D.F., Peng, Q., and Galarza, J.M. (1995) influenza A virus RNA polymerase subunit PB2 is the endonuclease which cleaves host cell mRNA and functions only as the trimeric enzyme. Virology 208: 38-47.
36. Singh, S.B. (1995) Total synthesis of flutimide, a novel endonuclease inhibitor of influenza virus. Tet Lett 36: 2009-2012.
37. Stoof, J.C., Booij, J., and Drukarch, B. (1992) Amantadine as N-methyl-aspartic acid receptor antagonist: new possibilities for therapeutic applications? Clin Neurol and Neurosurgery (Suppl) 94: S4-S6.
38. Tomassini, J., Selnick, H., Davies, M.E., Armstrong, M.E., Baldwin, J., Bourgeois, M., Hastings, J., Hazuda, D., Lewis, J., McClements, W., Ponticello, G., Radzilowski, E., Smith, G., Tebben, A., and Wolfe, A. (1994) Inhibition of cap (m7GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2,4-dioxobutanoic acid compounds. Antimicrob Agents Chemother 38: 2827-2837.
39. Tomassini, J.E., Davies, M.E., Hastings, J.C., Lingham, R., Mojena, M., Raghoobar, S.L., Singh, S.B., Tkacz, J.S., and Goetz, M.A. (1996) A novel antiviral agent which inhibits the endonuclease of influenza viruses. Antimicrob Agents Chemother 40: 1189-1193.
40. 7GpppNm) on RNAs and in initiating viral RNA transcription. Proc Natl Acad Sci USA 78: 7355-7359.
41. Webster, R.G., and Bean, W.J. (1978) Genetics of influenza virus. Ann Rev Genetics 12: 415-431.
42. Yamashita, M., Krystal, M., and Palese, P. (1989) Comparison of the three large polymerase proteins of influenza A, B, and C viruses. Virology 171: 458-466.